Longevity.Technology and Bio Atelier will discuss syringes, pens and pills – and why delivery may be more important than brand.
NAD Explained: Pills and Syringes and Pens – What Really Works?
Webinar – Wednesday 20 May at 3pm BST
NAD+ has become one of the most commercially visible molecules in long-term medicine, found everywhere from high-end clinics and functional medicine practices to consumer supplements and the crowded wellness markets. Despite the rapid expansion of the category, controversy remains around a simple question: what is the most effective way to deliver it?
This question is in our hearts upcoming webinar with Bio atelier May 20. Title NAD Explained: Pills and Syringes and Pens – What Really Works?The session brings together a mix of clinicians and industry leaders to dissect the implementation of delivery systems. We’re moving from the “what” to the “how” and we’re seeing the longevity therapeutics market really mature.
Longevity.Technology: NAD+ may be one of the few longevity molecules that has escaped the confines of clinics and biohacker forums and become almost mainstream—discussed in healthy spaces with the same casual confidence usually reserved for magnesium or creatine—but the scientific conversation surrounding it is just now subdued. Few people dispute the importance of NAD+ in cell regeneration and energy metabolism, or the fact that levels decline with age; More interesting questions relate to transport, bioavailability, and whether different approaches produce significantly different results in practice.
It is very transformative to watch. Not long ago, IV infusions had this elusive, “clinically exclusive” aura—a high-profile ritual that felt more like a medical event than a daily routine. Now, injections, pens, and liposomal formulations are entering the mainstream. Of course, biology rarely lends itself to a neat marketing statement, and one route is not a universal winner; instead, we’re finally seeing a shift away from the “miracle molecule” toward the stark reality of formula quality and whether the patient will actually adhere to the protocol.
From molecule to market
In webinars lands just as NAD+ finds itself in a middle-of-the-road crisis: scientifically sound enough for labs, but popular enough to risk flattening into a health cliché. It’s a crowded market, and the nuances often get lost in the noise.
Instead of looking at NAD+ as a one-size-fits-all fix, we look at the hard lines between swallowing a capsule and using a pen. We dive into the less interesting but vital components: absorption rates, the stress of daily use, and why translating petri dish biology into feeling “alive” is harder than it seems.
Bio Atelier – a familiar name here for their clinical-grade, mannitol-free focus – doesn’t sell as an educational deep dive, although they do walk us through their NAD+ pen, which we demo live.
That difference is everything. Longevity medicine is currently teetering between clinical rigor and an “I want it” consumer culture. As these interventions move into the hands of professionals, the challenge is to keep the science accurate without regulating the audience. It’s a delicate balance.
Clinical practice
In between webinars Dr. Rachna Murthy, who will discuss the clinical application of NAD+ in practice, along with Bio Atelier co-founders Myla Reeves and Trinity Gardiner, are expected to focus on implementation, development and patient experience.
The event also reflects a subtle but significant shift in longevity healthcare. Conversations move away from intervention as a bystander and toward operational questions—how treatments fit into existing clinical pathways, whether patients consistently adhere to them, and how practitioners communicate realistic expectations without entering the language of optimization theater.
In this sense, the debate surrounding NAD + delivery systems reflects the greater tension within the sector itself. Convenience competes with efficiency; consumer demand collides with the limits of evidence; innovation accelerates while consensus develops more slowly. Some treatments are developed because they work exceptionally well. Others, because they fit into modern life very well. Sometimes, the repetition is true.
Longevity variable vocabulary
What may ultimately prove most interesting is not whether one delivery method “wins” or not, but how the language around longevity interventions changes. Molecules that were previously discussed only in research settings are now appearing in mainstream health discourse, often divorced from the awareness and context that shaped their scientific origins.
The result is a real-time learning sector that is growing massively. Not interesting, maybe, but necessary.
Webinar NAD Explained: Pills and Syringes and Pens – What Really Works? It will be held on May 20 and is open to both practitioners and consumers. Registration is available via Zoom – CLICK HERE to be registered.
Photo courtesy of Bio Atelier
